drugset / Trial / NCT07043907
PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC
NaSingle-groupOpen-labelTreatment
Summary
A Single-center, Single-arm Clinical Trial on the Safety and Efficacy of PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Stage IIIA Non-Small Cell Lung Cancer
Timeline
- Start
- 2025-07-08
- Primary completion
- 2028-07-08
- Completion
- 2029-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PANK-003 | Cell therapy | — | — |